All Articles
Top officials for the FDA laid out new requirements limiting access to yearly COVID shots for healthy younger adults and children.
The congresswomen warn in a letter the “heightened health risks” for Black women exposed to the chemical, formaldehyde. U.S. Reps.
The ban removes it from the list of approved color additives in foods, dietary supplements and oral medicines, such as…
Reps. Shontel Brown, Ayanna Pressley and Nydia Velazquez want to know why the FDA delayed its date to propose a…
Civil rights leaders and Black organizations call on the Biden-Harris administration to end a delayed ruling to ban menthol cigarettes.
FDA’s approval was based on two large studies where some participants without diabetes lost about 18% of their body weight.
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends…
Perrigo’s once-a-day Opill will be available next year, and there will be no age restrictions on sales.
The U.S. Food and Drug Administration on Wednesday approved selling the leading version of naloxone without a prescription, setting the overdose-reversing drug…
Lawmakers are urging the FDA to prevent both the marketing and sale of e-cigarette nicotine products to middle and high…
Since 2000, some 22% of Liberia's tree cover has been lost to deforestation, largely due to pressure from logging and…
The Food and Drug Administration on Monday proposed making COVID-19 vaccinations more like the annual flu shot.
The clip-on devices that use light to measure oxygen levels in the blood are getting a closer look from U.S.…
About 48 percent of Americans who received their primary vaccinations have never received that all-important first booster.
The Food and Drug Administration assertion comes over two years after they declared Makena ineffective, which Covis Pharma challenges.
The FDA has given a green light for elementary school-age kids to get the updated booster doses made by Pfizer…
Shares of drugmakers researching Alzheimer’s disease soared Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the…
Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.